About Masimo Corp. 
Masimo Corp.
Pharmaceuticals & Biotechnology
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company's business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include non-invasive monitoring of blood constituents with an optical signature, optical organ oximetry monitoring, electrical, brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring. In addition, the Company has developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor, and the Radius-7 wearable wireless patient monitor. It offers Patient SafetyNet remote patient surveillance monitoring system, which allows patients to be monitored through a personal computer-based monitor or by care providers through their pagers, voice-over-Internet Protocol (IP) phones or smartphones.
Company Coordinates 
Company Details
52 Discovery , IRVINE CA : 92618-3105
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 104 Schemes (57.52%)
Foreign Institutions
Held by 234 Foreign Institutions (19.71%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Joseph Kiani
Chairman of the Board, Chief Executive Officer
Dr. Steven Barker
Director
Mr. H Michael Cohen
Independent Director
Mr. Sanford Fitch
Independent Director
Sen. (Retd.) Thomas Harkin
Independent Director
Mr. Adam Mikkelson
Independent Director
Revenue and Profits:
Net Sales:
371 Million
(Quarterly Results - Jun 2025)
Net Profit:
45 Million
Pharmaceuticals & Biotechnology
USD 10,544 Million (Small Cap)
409.00
NA
0.00%
0.45
5.63%
10.11






